170 related articles for article (PubMed ID: 37513474)
1. New Crystal Form of Human Neuropilin-1 b1 Fragment with Six Electrostatic Mutations Complexed with KDKPPR Peptide Ligand.
Goudiaby I; Malliavin TE; Mocchetti E; Mathiot S; Acherar S; Frochot C; Barberi-Heyob M; Guillot B; Favier F; Didierjean C; Jelsch C
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513474
[TBL] [Abstract][Full Text] [Related]
2. Architecture and hydration of the arginine-binding site of neuropilin-1.
Mota F; Fotinou C; Rana RR; Chan AWE; Yelland T; Arooz MT; O'Leary AP; Hutton J; Frankel P; Zachary I; Selwood D; Djordjevic S
FEBS J; 2018 Apr; 285(7):1290-1304. PubMed ID: 29430837
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
Baek DS; Kim JH; Kim YJ; Kim YS
Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
[TBL] [Abstract][Full Text] [Related]
4. Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.
Mota F; Yelland T; Hutton JA; Parker J; Patsiarika A; Chan AWE; O'Leary A; Fotinou C; Martin JF; Zachary IC; Djordjevic S; Frankel P; Selwood DL
Chembiochem; 2022 Jan; 23(1):e202100463. PubMed ID: 34647407
[TBL] [Abstract][Full Text] [Related]
5. The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
Kusunoki H; Tanaka T; Ohshima C; Sakamoto T; Wakamatsu K; Hamaguchi I
Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140708. PubMed ID: 34343702
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition.
Parker MW; Xu P; Guo HF; Vander Kooi CW
PLoS One; 2012; 7(11):e49177. PubMed ID: 23145112
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.
Parker MW; Xu P; Li X; Vander Kooi CW
J Biol Chem; 2012 Mar; 287(14):11082-9. PubMed ID: 22318724
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
Glinka Y; Prud'homme GJ
J Leukoc Biol; 2008 Jul; 84(1):302-10. PubMed ID: 18436584
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.
Kawamura H; Li X; Goishi K; van Meeteren LA; Jakobsson L; Cébe-Suarez S; Shimizu A; Edholm D; Ballmer-Hofer K; Kjellén L; Klagsbrun M; Claesson-Welsh L
Blood; 2008 Nov; 112(9):3638-49. PubMed ID: 18664627
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.
Roth L; Prahst C; Ruckdeschel T; Savant S; Weström S; Fantin A; Riedel M; Héroult M; Ruhrberg C; Augustin HG
Sci Signal; 2016 Apr; 9(425):ra42. PubMed ID: 27117252
[TBL] [Abstract][Full Text] [Related]
11. N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity.
Jia H; Aqil R; Cheng L; Chapman C; Shaikh S; Jarvis A; Chan AW; Hartzoulakis B; Evans IM; Frolov A; Martin J; Frankel P; Djordevic S; Zachary IC; Selwood DL
Chembiochem; 2014 May; 15(8):1161-70. PubMed ID: 24771685
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.
Fantin A; Herzog B; Mahmoud M; Yamaji M; Plein A; Denti L; Ruhrberg C; Zachary I
Development; 2014 Feb; 141(3):556-62. PubMed ID: 24401374
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity.
Sulpice E; Plouët J; Bergé M; Allanic D; Tobelem G; Merkulova-Rainon T
Blood; 2008 Feb; 111(4):2036-45. PubMed ID: 18065694
[TBL] [Abstract][Full Text] [Related]
14. VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.
Mehta V; Fields L; Evans IM; Yamaji M; Pellet-Many C; Jones T; Mahmoud M; Zachary I
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1845-1858. PubMed ID: 29880492
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin ligands in vascular and neuronal patterning.
Fantin A; Maden CH; Ruhrberg C
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1228-32. PubMed ID: 19909252
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction.
Jarvis A; Allerston CK; Jia H; Herzog B; Garza-Garcia A; Winfield N; Ellard K; Aqil R; Lynch R; Chapman C; Hartzoulakis B; Nally J; Stewart M; Cheng L; Menon M; Tickner M; Djordjevic S; Driscoll PC; Zachary I; Selwood DL
J Med Chem; 2010 Mar; 53(5):2215-26. PubMed ID: 20151671
[TBL] [Abstract][Full Text] [Related]
17. Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells.
Peach CJ; Kilpatrick LE; Friedman-Ohana R; Zimmerman K; Robers MB; Wood KV; Woolard J; Hill SJ
Cell Chem Biol; 2018 Oct; 25(10):1208-1218.e5. PubMed ID: 30057299
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 Acts as a Receptor for Complement Split Products.
Battin C; De Sousa Linhares A; Paster W; Isenman DE; Wahrmann M; Leitner J; Zlabinger GJ; Steinberger P; Hofer J
Front Immunol; 2019; 10():2209. PubMed ID: 31572401
[TBL] [Abstract][Full Text] [Related]
19. The cytoplasmic domain of neuropilin-1 regulates focal adhesion turnover.
Seerapu HR; Borthakur S; Kong N; Agrawal S; Drazba J; Vasanji A; Fantin A; Ruhrberg C; Buck M; Horowitz A
FEBS Lett; 2013 Nov; 587(21):3392-9. PubMed ID: 24021649
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 is a receptor for extracellular miRNA and AGO2/miRNA complexes and mediates the internalization of miRNAs that modulate cell function.
Prud'homme GJ; Glinka Y; Lichner Z; Yousef GM
Oncotarget; 2016 Oct; 7(42):68057-68071. PubMed ID: 27486976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
